心房颤动与中风的机制及治疗 - Suppr

Suppr

超能文献

Mechanisms and treatment of atrial fibrillation and stroke.

作者信息

Wang Shuai, Liu Zhi

机构信息

Department of Emergency, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.

出版信息

J Transl Int Med. 2025 Jul 30;13(4):305-307. doi: 10.1515/jtim-2025-0024. eCollection 2025 Aug.

DOI:10.1515/jtim-2025-0024

PMID:40861067

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12371395/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c748/12371395/9ef074bbf990/j_jtim-2025-0024_fig_001.jpg

相似文献

Mechanisms and treatment of atrial fibrillation and stroke.心房颤动与中风的机制及治疗

J Transl Int Med. 2025 Jul 30;13(4):305-307. doi: 10.1515/jtim-2025-0024. eCollection 2025 Aug.

Screening for Atrial Fibrillation With Electrocardiography: Evidence Report and Systematic Review for the US Preventive Services Task Force.心电图筛查心房颤动：美国预防服务工作组的证据报告和系统评价。

JAMA. 2018 Aug 7;320(5):485-498. doi: 10.1001/jama.2018.4190.

Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation.阿哌沙班预防非瓣膜性心房颤动的卒中。

N Engl J Med. 2024 Jan 11;390(2):107-117. doi: 10.1056/NEJMoa2310234. Epub 2023 Nov 12.

Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): statistical analysis plan for a randomised controlled trial.急性缺血性卒中合并心房颤动后抗凝治疗的最佳时机（OPTIMAS）：一项随机对照试验的统计分析计划

Trials. 2025 Feb 19;26(1):58. doi: 10.1186/s13063-025-08761-6.

Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks.用于预防非瓣膜性心房颤动且无既往卒中或短暂性脑缺血发作史患者卒中的口服抗凝药。

Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001927. doi: 10.1002/14651858.CD001927.pub2.

Very short paroxysms account for more than half of the cases of atrial fibrillation detected after stroke and TIA: a systematic review and meta-analysis.极短阵发作占卒中与短暂性脑缺血发作后检测到的房颤病例的半数以上：一项系统评价和荟萃分析。

Int J Stroke. 2015 Aug;10(6):801-7. doi: 10.1111/ijs.12555. Epub 2015 Jul 6.

Prevalence and associated factors of atrial fibrillation among acute stroke patients at public referral hospitals in Bahir Dar, Ethiopia, 2024: a cross-sectional study.2024年埃塞俄比亚巴赫达尔市公立转诊医院急性卒中患者心房颤动的患病率及相关因素：一项横断面研究

BMC Cardiovasc Disord. 2025 Jun 2;25(1):424. doi: 10.1186/s12872-025-04839-w.

Ischaemic events in hypertrophic cardiomyopathy patients with and without atrial fibrillation: a systematic review and meta-analysis.肥厚型心肌病伴或不伴心房颤动患者的缺血性事件：系统评价和荟萃分析。

J Thromb Thrombolysis. 2023 Jan;55(1):83-91. doi: 10.1007/s11239-022-02713-6. Epub 2022 Oct 3.

Warfarin and the Risk of Stroke and Bleeding in Patients With Atrial Fibrillation Receiving Dialysis: A Systematic Review and Meta-analysis.华法林与接受透析的心房颤动患者的中风和出血风险：一项系统评价和荟萃分析。

Can J Cardiol. 2017 Jun;33(6):737-746. doi: 10.1016/j.cjca.2017.02.004. Epub 2017 Feb 20.

Diagnosis of atrial fibrillation after stroke and transient ischaemic attack: a systematic review and meta-analysis.卒中与短暂性脑缺血发作后心房颤动的诊断：系统评价和荟萃分析。

Lancet Neurol. 2015 Apr;14(4):377-87. doi: 10.1016/S1474-4422(15)70027-X. Epub 2015 Mar 4.

本文引用的文献

Adv Sci (Weinh). 2024 Apr;11(14):e2307698. doi: 10.1002/advs.202307698. Epub 2024 Feb 2.

Atrial fibrillation and stroke: State-of-the-art and future directions.心房颤动与中风：现状与未来方向。

Curr Probl Cardiol. 2024 Jan;49(1 Pt C):102181. doi: 10.1016/j.cpcardiol.2023.102181. Epub 2023 Oct 31.

Atrial Cardiomyopathy: Pathophysiology and Clinical Consequences.心房心肌病：病理生理学与临床后果。

Cells. 2021 Sep 30;10(10):2605. doi: 10.3390/cells10102605.

Predictors of Atrial Fibrillation Development in Patients With Embolic Stroke of Undetermined Source: An Analysis of the RE-SPECT ESUS Trial.不明来源栓塞性卒中患者心房颤动发展的预测因素：RE-SPECT ESUS 试验分析。

Circulation. 2021 Nov 30;144(22):1738-1746. doi: 10.1161/CIRCULATIONAHA.121.055176. Epub 2021 Oct 15.

Activated clotting factor X mediates mitochondrial alterations and inflammatory responses via protease-activated receptor signaling in alveolar epithelial cells.激活的凝血因子 X 通过肺泡上皮细胞中的蛋白酶激活受体信号转导介导线粒体改变和炎症反应。

Eur J Pharmacol. 2020 Feb 15;869:172875. doi: 10.1016/j.ejphar.2019.172875. Epub 2019 Dec 23.

Recurrent Stroke With Rivaroxaban Compared With Aspirin According to Predictors of Atrial Fibrillation: Secondary Analysis of the NAVIGATE ESUS Randomized Clinical Trial.依房颤预测因子评估，利伐沙班与阿司匹林比较用于复发性卒中： NAVIGATE ESUS 随机临床试验的二次分析。

JAMA Neurol. 2019 Jul 1;76(7):764-773. doi: 10.1001/jamaneurol.2019.0617.

Interleukin-6 and C-reactive protein and risk for death and cardiovascular events in patients with atrial fibrillation.白细胞介素-6和C反应蛋白与心房颤动患者的死亡及心血管事件风险

Am Heart J. 2015 Dec;170(6):1151-60. doi: 10.1016/j.ahj.2015.09.018. Epub 2015 Oct 3.

Histological substrate of human atrial fibrillation.人类心房颤动的组织学基础。

Biomed Pharmacother. 2010 Mar;64(3):177-83. doi: 10.1016/j.biopha.2009.09.017. Epub 2009 Nov 18.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验